An angiotensin II-and NF-κB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension

Cardiovascular Research

Volumn 87, Issue 1, 2010, Pages 166-176

  Alonso, Florian ^a   Krattinger, Nathalie ^a   Mazzolai, Lucia ^a   Simon, Alexander ^b   Waeber, Gérard ^a   Meda, Paolo ^c   Haefliger, Jacques Antoine ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Angiotensin II; Aorta; Arteries; Cx37; Cx40; Cx43; Cx45; Gap junctions; Hypertension; NF B; Renin; Transgenic mice

Indexed keywords

ANGIOTENSIN II; CONNEXIN 37; CONNEXIN 40; CONNEXIN 43; CONNEXIN 45; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; N(G) NITROARGININE METHYL ESTER; RENIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GAP JUNCTION PROTEIN; GJA1 PROTEIN, MOUSE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA WALL; ARTERIAL WALL THICKENING; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; GAP JUNCTION; HYPERTENSION; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; AORTA; BINDING SITE; BLOOD; BLOOD PRESSURE; C57BL MOUSE; CAROTID ARTERY; CELL LINE; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; HYPERTENSION, RENOVASCULAR; KNOCKOUT MOUSE; MESENTERIC ARTERY; METABOLISM; MOUSE; NEPHRECTOMY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROMOTER REGION; RAT; REPORTER GENE; SMOOTH MUSCLE FIBER; TIME; UPREGULATION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA; BINDING SITES; BLOOD PRESSURE; CAROTID ARTERIES; CELL LINE; CONNEXIN 43; CONNEXINS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENES, REPORTER; HYPERTENSION, RENOVASCULAR; MESENTERIC ARTERIES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; NEPHRECTOMY; NF-KAPPA B; NG-NITROARGININE METHYL ESTER; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; RATS; RENIN; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 77955143584     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq031     Document Type: Article

References (50)

1. Haefliger JA, Nicod P, Meda P. Contribution of connexins to the function of the vascular wall. Cardiovasc Res 2004;62:345-356.
2. Simon AM, McWhorter AR. Decreased intercellular dye-transfer and downregulation of non-ablated connexins in aortic endothelium deficient in connexin37 or con-nexin40. J Cell Sci 2003;116:2223-2236.
3. Kruger O, Beny JL, Chabaud F, Traub O, Theis M, Brix K et al. Altered dye diffusion and upregulation of connexin37 in mouse aortic endothelium deficient in connexin40. J Vasc Res 2002;39:160-172.
4. Brisset AC, Isakson BE, Kwak BR. Connexins in vascular physiology and pathology. Antioxid Redox Signal 2009;11:267-282.
5. Haefliger JA, Krattinger N, Martin D, Pedrazzini T, Capponi A, Doring B et al. Connexin43-dependent mechanism modulates renin secretion and hypertension. J Clin Invest 2006;116:405-413.
6. Figueroa XF, Duling BR. Gap junctions in the control of vascular function. Antioxid Redox Signal 2009;11:251-266.
7. Krattinger N, Capponi A, Mazzolai L, Aubert JF, Caille D, Nicod P et al. Connexin40 regulates renin production and blood pressure. Kidney Int 2007;72:814-822.
8. Wagner C, de Wit C, Kurtz L, Grunberger C, Kurtz A, Schweda F. Connexin40 is essential for the pressure control of renin synthesis and secretion. Circ Res 2007; 100:556-563.
9. Kurtz L, Schweda F, de Wit C, Kriz W, Witzgall R, Warth R et al. Lack of connexin 40 causes displacement of renin-producing cells from afferent arterioles to the extraglo-merular mesangium. J Am Soc Nephrol 2007;18:1103-1111.
10. Wagner C. Function of connexins in the renal circulation. Kidney Int 2008;73: 547-555.
11. Krattinger N, Alonso F, Capponi A, Mazzolai L, Nicod P, Meda P et al. Increased expression of renal cyclooxygenase-2 and neuronal nitric oxide synthase in hypertensive Cx40-deficient mice.J Vasc Res 2009;46:188-198.
12. Zanchi A, Wiesel P, Aubert JF, Brunner HR, Hayoz D. Time course changes of the mechanical properties of the carotid artery in renal hypertensive rats. Hypertension 1997;29:1199-1203.
13. Fitch RM, Rutledge JC, Wang YX, Powers AF, Tseng JL, Clary T et al. Synergistic effect of angiotensin II and nitric oxide synthase inhibitor in increasing aortic stiffness in mice. Am J Physiol Heart Circ Physiol 2006;290:H1190-H1198.
14. Yasmin, O'Shaughnessy KM. Genetics of arterial structure and function: towards new biomarkers for aortic stiffness? Clin Sci (Lond) 2008;114:661-677.
15. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 2005;45:1050-1055.
16. Safar ME, Thuilliez C, Richard V, Benetos A. Pressure-independent contribution of sodium to large artery structure and function in hypertension. Cardiovasc Res 2000; 46:269-276.
17. Safar ME, Boudier HS. Vascular development, pulse pressure, and the mechanisms of hypertension. Hypertension 2005;46:205-209.
18. Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T. Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension 1997;29:1025-1030.
19. Kirchhoff S, Nelles E, Hagendorff A, Kruger O, Traub O, Willecke K. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr Biol 1998;8:299-302.
20. Mazzolai L, Nussberger J, Aubert JF, Brunner DB, Gabbiani G, Brunner HR et al. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 1998;31:1324-1330.
21. Fluckiger JP, Gremaud G, Waeber B, Kulik A, Ichino A, Nussberger J et al. Measurement of sympathetic nerve activity in the unanesthetized rat. J Appl Physiol 1989;67: 250-255.
22. Haefliger JA, Castillo E, Waeber G, Bergonzelli GE, Aubert JF, Sutter E et al. Hypertension increases connexin43 in a tissue-specific manner. Circulation 1997;95: 1007-1014.
23. Mederos y, Schnitzler M, Storch U, Meibers S, Nurwakagari P, Breit A et al. Gq-coupled receptors as mechanosensors mediating myogenic vasoconstriction. EMBO J 2008;27:3092-3103.
24. Skutella M, Ruegg UT. Studies on capacitative calcium entry in vascular smooth muscle cells by measuring 45CA2+ influx. J Recept Signal Transduct Res 1997;17: 163-175.
25. Skutella T, Savaskan NE, Ninnemann O, Nitsch R. Target-and maturation-specific membrane-associated molecules determine the ingrowth of entorhinal fibers into the hippocampus. Dev Biol 1999;211:277-292.
26. Simon AM, Chen H, Jackson CL. Cx37 and Cx43 localize to zona pellucida in mouse ovarian follicles. Cell Commun Adhes 2006;13:61-77.
27. Haefliger JA, Demotz S, Braissant O, Suter E, Waeber B, Nicod P et al. Connexins 40 and 43 are differentially regulated within the kidneys of rats with renovascular hypertension. Kidney Int 2001;60:190-201.
28. Allagnat F, Alonso F, Martin D, Abderrahmani A, Waeber G, Haefliger JA. ICER-1 gamma overexpression drives palmitate-mediated connexin36 down-regulation in insulin-secreting cells. J Biol Chem 2008;283:5226-5234.
29. Martin D, Allagnat F, Chaffard G, Caille D, Fukuda M, Regazzi R et al. Functional significance of repressor element 1 silencing transcription factor (REST) target genes in pancreatic beta cells. Diabetologia 2008;51:1429-1439.
30. Burnier M. Spotlight on renin. The renin-angiotensin-aldosterone system and metabolic syndrome. J Renin Angiotensin Aldosterone Syst 2006;7:184.
31. Mehta PK, Griendling KK Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82-C97.
32. Mazzolai L, Pedrazzini T, Nicoud F, Gabbiani G, Brunner HR, Nussberger J. Increased cardiac angiotensin II levels induce right and left ventricular hypertrophy in normoten-sive mice. Hypertension 2000;35:985-991.
33. Stanton AV, Gradman AH, Schmieder RE, Nussberger J, Sarangapani R, Prescott MF. Aliskiren monotherapy does not cause paradoxical blood pressure rises. meta-analysis of data from 8 clinical trials. Hypertension 2010;55:54-60.
34. Abe F, Omata K, Yamada M, Tsunoda K, Sato T, Shimizu T et al. Specific direct radioimmunoassay of angiotensin II (AT II) in human plasma and the effect of angiotensin converting enzyme (ACE) inhibitor. Immunopharmacology 1999;44:199-204.
35. Kiribayashi K, Masaki T, Naito T, Ogawa T, Ito T, Yorioka N et al. Angiotensin II induces fibronectin expression in human peritoneal mesothelial cells via ERK1/2 and p38 MAPK. Kidney Int 2005;67:1126-1135.
36. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 2002;109(Suppl.): S81-S96.
37. Levrand S, Pesse B, Feihl F, Waeber B, Pacher P, Rolli J et al. Peroxynitrite is a potent inhibitor of NF-{kappa}B activation triggered by inflammatory stimuli in cardiac and endothelial cell lines. J Biol Chem 2005;280:34878-34887.
38. Teunissen BE, Jansen AT, van Amersfoorth SC, O'Brien TX, Jongsma HJ, Bierhuizen MF. Analysis of the rat connexin 43 proximal promoter in neonatal cardi-omyocytes. Gene 2003;322:123-136.
39. Fanchaouy M, Bychkov R, MeisterJJ, BenyJL Stretch-elicited calcium responses in the intact mouse thoracic aorta. Cell Calcium 2007;41:41-50.
40. Haefliger JA, Meda P, Formenton A, Wiesel P, Zanchi A, Brunner HR et al. Aortic con-nexin43 is decreased during hypertension induced by inhibition of nitric oxide synthase. Arterioscler Thromb Vasc Biol 1999;19:1615-1622.
41. Figueroa XF, Isakson BE, Duling BR. Vascular gap junctions in hypertension. Hypertension 2006;48:804-811.
42. Cheng G, Kim MJ, Jia G, Agrawal DK. Involvement of chloride channels in IGF-I-induced proliferation of porcine arterial smooth muscle cells. Cardiovasc Res 2007;73: 198-207.
43. Cui R, Tieu B, Recinos A, Tilton RG, Brasier AR. RhoA mediates angiotensin II-induced phospho-Ser536 nuclear factor kappaB/RelA subunit exchange on the interleukin-6 promoter in VSMCs. Circ Res 2006;99:723-730.
44. Bonizzi G, Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004;25:280-288.
45. Safar ME, Jankowski P. Central blood pressure and hypertension: role in cardiovascular risk assessment. Clin Sci (Lond) 2009;116:273-282.
46. Haefliger JA, Tissieres P, Tawadros T, Formenton A, Beny JL, Nicod P et al. Connexins 43 and 26 are differentially increased after rat bladder outlet obstruction. Exp Cell Res 2002;274:216-225.
47. Sakurabayashi-Kitade S, Aoka Y, Nagashima H, Kasanuki H, Hagiwara N, Kawana M. Aldosterone blockade by spironolactone improves the hypertensive vascular hypertrophy and remodeling in angiotensin II overproducing transgenic mice. Atherosclerosis 2009;206:54-60.
48. Tham DM, Martin-McNulty B, Wang YX, Da Cunha V, Wilson DW, Athanassious CN et al. Angiotensin II injures the arterial wall causing increased aortic stiffening in apo-lipoprotein E-deficient mice. Am J Physiol Regul Integr Comp Physiol 2002;283: R1442-R1449.
49. Wang YX, Fitch RM. Vascular stiffness: measurements, mechanisms and implications. Curr Vasc Pharmacol 2004;2:379-384.
50. Dzau VJ. Mechanism of protective effects of ACE inhibition on coronary artery disease. Eur Heart J 1998;19(Suppl. J):J2-J6.